Data CRO | Global Clinical Research & Health Data Analytics Company

THE DIFFERENCE IS IN THE DATA™

Strong science, strength of process, and a sense of urgency, MMS is redefining the CRO experience. Gain new insights from our data-focused and tech-enabled team of experts.

LEARN MORE

SPONSORS TRUST MMS WITH THEIR SUBMISSIONS

Our integrated regulatory, writing, publishing, and QC teams have developed effective strategies and led data planning, summarization, and lifecycle management for 50+ marketing applications in the past 5 years.

DISCOVER MMS

MODERN FSP SOLUTIONS FOR AN EVOLVING INDUSTRY

Our FSP models are designed to be flexible and scalable, bringing expertise that will increase levels of productivity to align with your organization’s goals.

SEE KEY BENEFITS

MMS JOINS DECENTRALIZED TRIALS & RESEARCH ALLIANCE

DTRA’s mission is to make clinical trial participation widely accessible by advancing policies, research practices, and new technology in decentralized clinical research.

DATA SCIENTISTS ACHIEVING NEW LEVELS OF INSIGHT

With deep regulatory expertise, strong processes, and purpose-built, flexible technology, our data science experts work to uncover new insights on disease, compound, patient, and operational improvements.

EXPLORE OUR SOLUTIONS

A WINNING DEVELOPMENT STRATEGY

MMS provides insights into your development plans, including global strategies for expedited regulatory approval and a track record of on-time delivery utilizing our trademarked APP process.

EXPLORE OUR SOLUTIONS

Regulatory Affairs
& Operations

Data Management
& Biostatistics

Regulatory &
Medical Writing

Drug Safety &
Pharmacovigilance

Quality & Compliance
Services

Transparency
Services

Helping sponsors navigate a complex regulatory environment

MMS is an award-winning, data-focused clinical research organization (CRO) that supports the pharmaceutical, biotech, and medical device industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience and a data-driven approach to drug development make MMS a valuable CRO partner, creating compelling submissions that meet rigorous regulatory standards.

Industry experts across 4 continents are available to support your programs 24×7 with a 97 percent sponsor satisfaction rating

“MMS is the only company I would reach out to, big or small. MMS understood and worked within our capabilities and with our unconventional strategies we were forced into by the nature of being small and underfunded. Your team worked with us, diligently, beyond expectations, and got us over the finish line to success.” —Sr. Vice President, Research & Development, Small Pharma

“This team never stopped working towards our deadline, and from day one, we were impressed with the efficient and smart decisions brought forth by MMS to bring this drug to market.” —Randy Brenner, Senior Vice President Global Regulatory Affairs, Quality, and Technical Operations, Paratek

“We work with a lot of CROs and consultants here in Boston. They’re good, they do fine, but you guys are the standard.” — Senior Director, Clinical Quality Assurance, Large Pharma

“MMS consistently provides our team with the highest level of detail and quality work in every task that they undertake. I am pleased that we were able to attain this fast track status and look forward to working with MMS as we continue into the phase three studies.” — Dr. Doo Lee, CEO and Head of Research and Development, Vivozon

“The choice in collaborating with MMS to meet this milestone… was simple, given their deep scientific knowledge and strategic resource models,” — Dr. Steven Gullans, CEO, Gemphire

Latest News

Senior Biopharma Executive Joins MMS Holdings as Principal Medical Director

Dr. Allen has worked at Parke Davis, Pfizer, Adolor, AstraZeneca, Wyeth, Scirex, Premier, and Inventive/ Syneos. In recent years, he has served as Chief Medical Officer for several start-up companies, including Afferent, Centrexion and Concentric Pharmaceuticals. Read more.

Latest Webinar

View our webinar on Strategies for Navigating ICH E9(R1)

In this Experts Insights webinar, The ICH E9(R1) Addendum on ‘Estimands and Sensitivity Analysis in Clinical Trials’ introduced a framework to align planning, design, conduct, analysis, and interpretation of clinical trials. Watch here.

Innovation News

MMS Holdings Wins Scrip 2021 Best CRO Award

The Scrip Awards, held annually by London-based Informa Pharma Intelligence, honors outstanding achievements of organizations in the pharmaceutical, biotech and allied industries. The award for Best Contract Research Organization-Specialist Provider recognizes MMS for exceeding Sponsor expectations, bringing innovations to the industry, improving data quality and and streamlining data collection and reporting through the Decentralized Trials and Research Alliance (DTRA). Read more

Featured Sponsor

SUBMISSION SUPPORT FOR PARATEK PHARMACEUTICALS GARNERS FDA APPROVAL AND SUCCESSFUL MAA FILING

MMS supported Paratek Pharmaceuticals, Inc. for the new drug application (NDA) approval and successful marketing authorisation application (MAA) filing of NUZYRA™ (omadacycline) for the treatment of adults with community-acquired bacterial pneumonia (CABP) and acute skin and skin structure infections (ABSSSI). Get the details

The best life science service and technology solutions, begin with the best sponsors and alliance partners.

6880 Commerce Blvd.
Canton, MI 48187 USA
734.245.0310 T
734.245.0320 F

SITEMAP

OUR SERVICES

Regulatory Affairs and Operations

Data Management and Biostatistics

Regulatory and Medical Writing

Drug Safety and Pharmacovigilance

Quality and Compliance Services

Transparency Services

Rare Disease Services

Quality Control Serivces

Project Advisory Services

Functional Service Provider

CONNECT WITH US

Cookie	Duration	Description
cookielawinfo-checbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.